title: Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic.
abstract: OBJECTIVE
  Patients having undergone allogeneic stem cell transplantation (SCT) require complex medication regimens. To ensure the safe and effective management of this patient group, specialised care in a centre with a dedicated and experienced healthcare team is essential. The aim of this study was to evaluate the effectiveness of a specialty clinical pharmacist working in an ambulatory SCT clinic.
  
  
  METHODS
  A prospective cohort study was conducted on patients post SCT and discharged to the ambulatory setting. Patients were reviewed by a clinical pharmacist weekly for six visits. At these visits a medication review was undertaken. Interventions from these reviews were recorded. Interventions were then assigned a risk rating by a multidisciplinary panel. Adherence was also assessed by a Morisky questionnaire and review of dose administration aids. Comparison of data over the six-visit period was undertaken.
  
  
  RESULTS
  In total 23 patients were enrolled in the study. All six visits were completed in 17 patients and 161 interventions were recorded at an average of 1.4 interventions per patient visit. The panel rated 40 % of interventions as high risk, 46 % as medium risk and 14 % as low risk. At all visit points high- and medium-risk interventions constituted >80 % of the total. Morisky scores improved by an average of 1.53 (p < 0.0001) between visits 1 and 6. All patients were scored as highly adherent by visit 6.
  
  
  CONCLUSIONS
  A specialist clinical pharmacist in the SCT outpatient clinic resulted in regular and effective intervention contributing to improved medication management and adherence.
authors: Pharmacy Department, Alfred Health, 55 Commercial Road, Melbourne, 3004, Australia, r.chieng@alfred.org.au.
authors: Ruth
authors: R
authors: Chieng
authors: John
authors: J
authors: Coutsouvelis
authors: Susan
authors: S
authors: Poole
authors: Michael J
authors: MJ
authors: Dooley
authors: Diana
authors: D
authors: Booth
authors: Andrew
authors: A
authors: Wei
mesh_terms: D000293:Adolescent; D000328:Adult; D000554:Ambulatory Care Facilities / Q000458:organization & administration*; D015331:Cohort Studies; D003266:Continuity of Patient Care; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D010595:Pharmacists / Q000458:organization & administration*; D011446:Prospective Studies; D033581:Stem Cell Transplantation / Q000379:methods*; D014184:Transplantation, Homologous; D055815:Young Adult
references: Int J Clin Pharm. 2012 Feb;34(1):27-31
references: 22207272
references: CA Cancer J Clin. 1996 May-Jun;46(3):142-64
references: 8646545
references: Am J Health Syst Pharm. 2002 Mar 1;59(5):447-52
references: 11887411
references: Ann Pharmacother. 2006 Sep;40(9):1527-33
references: 16882869
references: Arch Intern Med. 1999 Sep 13;159(16):1939-45
references: 10493325
references: BMJ. 2006 Jul 1;333(7557):15
references: 16790458
references: Am J Health Syst Pharm. 2001 Jul 15;58(14):1330-7
references: 11471481
references: Ann Intern Med. 1992 Mar 15;116(6):505-12
references: 1739242
references: Am J Health Syst Pharm. 2011 Apr 1;68(7):613-9
references: 21411803
references: Med Care. 1986 Jan;24(1):67-74
references: 3945130